All In MedTech

Device Trial Radar · NCT03648775

Evaluation of the Clinical Efficacy of Y-STRUT® Medical Device Implanted for Contralateral Percutaneous Internal Fixation of Proximal Femur, in Patient With a Low Energy Per Trochanteric Fracture on the First Side

National, Multicentre, Prospective, Observational Study, to Evaluate the Clinical Efficacy of Y-STRUT® Medical Device Implanted for Contralateral Percutaneous Internal Fixation of Proximal Femur, in Patient With a Low Energy Per Trochanteric Fracture on the First Side

Last checked: Nov 20, 2026Latest source record: Apr 29, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

Terminated

Status

Terminated

Enrollment

10

Actual

Start

Dec 6, 2017

Primary completion

Mar 24, 2020

Study completion Mar 24, 2020

Sponsor

Lead sponsor
HypreventionNot on our public-company list
Sponsor type
Industry
First posted
Aug 27, 2018

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes, from 60 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

HIP50 is a national, multicentre, prospective, observational study, in patients presenting a first low energy per trochanteric hip fracture on one side and treated with Y-STRUT® device implanted on the contralateral proximal femur as percutaneous internal fixation to prevent contralateral hip fracture in case of osteoporosis. The primary objective of this study is to evaluate the clinical efficacy of the studied medical device by measuring the frequency of patient with a fracture at the implantation site within 1 year after implantation. A total of 50 patients from France will be enrolled (until December 2020) and followed up to 24 months.

Conditions

  • Fracture of Hip
  • Osteoporosis

Interventions

  • Y-STRUT® (Hyprevention, Pessac, France)Device

    The studied medical device consists of two components implanted in the proximal femur, combined with bone cement.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Frequency of post-operative fracture [Clinical efficacy of the device]Time frame: At 12 months

Locations

5 sites in 1 country. Site status is shown where the registry gives one.

  • Hôpital Privé d'Ambérieu

    Ambérieu-en-Bugey, France

  • Hôpital Antoine Béclère

    Clamart, France

  • Centre Hospitalier Universitaire Grenoble Alpes

    La Tronche, France

2 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.